Caris Life Sciences, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2022 | — | $-1.70B | — |
| Dec 2023 | — | $-2.14B | — |
| Mar 2024 | — | $-2.27B | — |
| Jun 2024 | — | $-2.36B | — |
| Sep 2024 | — | $-2.44B | — |
| Dec 2024 | $319.4M | $-2.50B | $64.0M |
| Mar 2025 | — | $-2.60B | $31.2M |
| Jun 2025 | $373.6M | $452.9M | $718.9M |
| Sep 2025 | $376.3M | $478.4M | $753.2M |
| Dec 2025 | $378.8M | $577.3M | $796.3M |
| Mar 2026 | $381.4M | $593.5M | $819.9M |
| Jun 2026 | $393.0M | $591.7M | — |